smallAccCompHo_0921.xslt
Company Registration No. 13441054 (England and Wales)
NEURONE LIMITED
Financial Statements
for the Period from 01 January 2024 to 31 December 2024

NEURONE LIMITED

Financial Statements for the period ending 31 December 2024

NEURONE LIMITED

Financial Statements for the period ending 31 December 2024

Notes to the Accounts

1. Statutory Information
NEURONE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 13441054.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.
Presentation Currency
The accounts are presented in £ sterling.

NEURONE LIMITED

Financial Statements for the period ending 31 December 2024

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2024 3
2023 0
4. Principal Activity
The Company is engaged in Research and Development of prescription pharmaceuticals

NEURONE LIMITED

Financial Statements for the period ending 31 December 2024

Notes to the Accounts

5. Fixed Assets
Plant and Machinery Total
Cost or valuation £ £
At 01/01/2024 - -
Additions 41,275 41,275
At 31/12/2024 41,275 41,275
Depreciation
At 01/01/2024 - -
Charge for the year 3,440 3,440
At 31/12/2024 3,440 3,440
Net Book Value
At 31/12/2024 37,835 37,835
At 31/12/2023 - -